Alterations in Cerebrospinal Fluid Proteins in a Presymptomatic Primary Glioma Model

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Whitin, John C ^a   Jang, Taichang ^a   Merchant, Milton ^a   Yu, Tom T S ^a   Lau, Kenneth ^a   Recht, Benjamin ^b   Cohen, Harvey J ^a   Recht, Lawrence ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Wisconsin Madison   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 1 MACROGLOBULIN; ETHYLNITROSOUREA; MACROGLOBULIN; NESTIN; PREALBUMIN; UNCLASSIFIED DRUG;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CISTERNA MAGNA; CONTROLLED STUDY; DISEASE MODEL; FALSE DISCOVERY RATE; FEMALE; GLIOMA; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; RAT; STATISTICAL ANALYSIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ANIMALS; BIOLOGICAL MARKERS; BRAIN; BRAIN NEOPLASMS; CEREBROSPINAL FLUID PROTEINS; DISEASE MODELS, ANIMAL; ETHYLNITROSOUREA; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; GLUTATHIONE; INTERMEDIATE FILAMENT PROTEINS; NERVE TISSUE PROTEINS; PROTEOME; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

ANIMALIA; RATTUS; RODENTIA;

EID: 84869779517     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049724     Document Type: Article

References (51)

1. Joshi A, Cao D, (2010) TGF-beta signaling, tumor microenvironment and tumor progression: the butterfly effect. Front Biosci 15: 180-194.
2. Liu AY, Pascal LE, Vencio RZ, Vencio EF, (2011) Stromal-epithelial interactions in early neoplasia. Cancer Biomark 9: 141-155.
3. van Kempen LC, de Visser KE, Coussens LM, (2006) Inflammation, proteases and cancer. Eur J Cancer 42: 728-734.
4. Cserr HF, (1988) Role of secretion and bulk flow of brain interstitial fluid in brain volume regulation. Ann NY Acad Sci 529: 9-20.
5. Skipor J, Thiery J-C, (2008) The choroid plexus- cerebrospinal fluid system: Undervaluated pathway of neurendocrine signaling into the brain. Acta Neurobiol Exp 68: 414-428.
6. Fung ET, Yip TT, Lomas L, Wang Z, Yip C, et al. (2005) Classification of cancer types by measuring variants of host response proteins using SELDI serum assays. Int J Cancer 115: 783-789.
7. Soltys SG, Le QT, Shi G, Tibshirani R, Giaccia AJ, et al. (2004) The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamouse cell cancers. Clinical Cancer Res 10: 4806-4812.
8. Wadsworth JT, Somers KD, Stack BC, Cazares L, Malik G, et al. (2004) Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg 130: 98-104.
9. Zhang Z, Bast RC, Yu Y, Li J, Sokoll LJ, et al. (2004) Three biomarkers identified from serum proteomic analysis for the detection at early stage ovarian cancer. Cancer Res 64: 5882-5890.
10. Jang T, Litofsky NS, Smith TS, Ross A, Recht L, (2004) Aberrant nestin expression during ethylnitrosourea-(ENU)-induced neurocarcinogenesis. Neurobiology of Disease 15: 544-552.
11. Jang T, Savarese T, Low HP, Kim S, Vogel H, et al. (2006) Osteopontin (OPN) expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea (ENU). Amer J Pathology 168: 1676-1685.
12. Jang T, Sathy B, Hsu Y-H, Recht B, Chang C-C, et al. (2008) Gliomas undergo a distinct phenotypic change as the time of MRI detection. J Neurosurgery 108: 782-790.
13. Lim A, Prokaeva T, McComb ME, Connors LH, Skinner M, et al. (2003) Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis. Protein Science 12: 1775-1786.
14. Tibshirani R, (1996) Regression shrinkage and selection via the Lasso. J Royal Statistical Soc, B 58: 267-288.
15. Efron B, Hastie T, Johnstone Tibshirani R, (2004) Least angle regression. Annals of Statistics 32: 407-499.
16. Osborne MR, Presnell B, Turlach BA, (2000) A new approach to variable selection in least squares problems. IMA Journal of Numerical Analysis 20: 389-403.
17. Ikeda T, Mashimoto H, Iwasaki K, Shimokawa I, Matsuo T, (1989) A sequential ultrastructural and histoautoradiographic study of early neoplastic lesions in ethylnitrosourea-induced rat glioma. Acta Pathol Jpn 39: 487-495.
18. Lantos PL, Cox DJ, (1976) The origin of experimental brain tumours: A sequential study. Experientia 32: 1467-1468.
19. Lantos PL, Pilkington GJ, (1979) The development of experimental brain tumors. A sequential light and electron microscope study of the subependymal plate. I. Early lesions (Abnormal cell clusters). Acta Neuropathol 45: 167-175.
20. Mennel HD, Simon H, (1985) Morphology of early stages of ENU-induced brain tumors in rats. Exp Pathology 28: 207-214.
21. Pilkington GJ, Lantos PL, (1979) The development of experimental brain tumors. A sequential light and electron microscope study of the subependymal plate. II. Microtumors. Acta Neuropathol (Berl) 45: 177-185.
22. Schiffer D, Giordana MT, Pezzotta S, Lechner C, Paoletti P, (1978) Cerebral tumors induced by transplacental ENU: Study of the different tumoral stages, particularly of early proliferations. Acta Neuropathol 41: 27-31.
23. Schiffer D, Giordana MT, Mauro A, Racagni G, Bruno F, et al. (1980) Experimental brain tumors by transplacental ENU. Multifactorial study of the latency period. Acta Neuropathol 49: 117-122.
24. Yoshino T, (1985) Morphological maturation of tumor cells induced by ethylnitrosourea (ENU) in rat brains. II. On the tumors by administration of ENU in the mid-gestational stage. Acta Pathol Jpn 35: 1397-1408.
25. Yoshino T, Motoi M, Ogawa K, (1985) Immunohistochemical studies on cellular character of microtumors induced by ethylnitrosourea in the rat brain utilizing anti-Leu 7 and anti-glial fibrillary acidic protein antibodies. Acta Neuropathol 66: 167-169.
26. Thomsen CE, Kornegay JN, Stevens JB, (1990) Analysis of cerebrospinal fluid from the cerebellomedullary and lumbar cisterns of dogs with focal neurologic disease: 145 cases (1985-1987). J Am Vet Med Assoc 196: 1841-1844.
27. Weisher B, Bernheardt W, (1978) Protein fractions of lumbar cisternal, and ventricular cerebrospinal fluid. Separate areas of reference. J Neurol Sci 37: 205-214.
28. Khwaja FW, Duke-Cohan JS, Brat DJ, Van Meir E, (2006) Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration. Clinical Cancer Res 12: 6331-6336.
29. Roy S, Josephson SA, Fridlyand J, Karch J, Kadoch C, et al. (2008) Protein biomarker identification in the CSF of patients with CNS lymphoma. J Clinical Oncology 26: 96-105.
30. Schuhmann MJ, Zucht HD, Nassimi R, Heine G, Schneekloth CG, et al. (2010) Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme. Eur J Surg Oncol 36(2): 201-207.
31. Zhang H, Wu G, Tu H, Huang F, (2007) Discovery of serum biomarkers in astrocytoma by SELDI-TOF MS and proteinchip technology. J Neurooncol 84: 315-323.
32. You J-S, Gelfanova V, Knierman MD, Witzmann FA, Wang M, et al. (2005) The impact of blood contamination on the proteome of cerebrospinal fluid. Proteomics 5: 290-296.
33. Melegos DN, Freedman MS, Diamandis EP, (1997) Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neuirological disorders. Prostaglandins 54: 463-474.
34. Tomani H, Nau R, Felgenhauer K, (1998) Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases. Ann Neurol 44: 882-889.
35. Beuckmann CT, Lazarus M, Gerashchenko D, Mizoguchi A, Nomura S, et al. (2000) Cellular localization of lipocalin-type prostaglandin D synthase (b-trace) in the central nervous system of the adult rat. J Comp Neurology 428: 62-78.
36. Urade Y, Hayaishi O, (2000) Prostaglandin D synthase: Structure and Function. Vitamins and Hormones 58: 89-120.
37. Payne CA, Maleki S, Messina M, O'Sullivan MG, Stone G, et al. (2008) Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytoma. Mol Cancer Ther 7: 3420-3428.
38. Rajagopal MU, Hathout Y, MacDonald TJ, Kieran MW, Gururangan S, et al. (2011) Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study. Proteomics 11: 1-9.
39. Sottrup-Jensen L, (1989) Alpha-macroglobulin: Structure, shape, and mechanism of proteinase complex formation. J Biological Chemistry 264: 11539-11542.
40. Herbert J, Wilcox JN, Pham KT, et al. (1986) Transthyretin: a choroid plexus-specific transport protein in human brain. Neurology 36: 900-911.
41. Lignelid H, Collins VP, Jacobsson B, (1997) Cystatin C and transthyretin expression in normal and neoplastic tissues of the human brain and pituitary. Acta Neuropathologica 93: 494-500.
42. Park CK, Jung JH, Park SH, Jung HW, Cho BK, (2009) Multifarious proteomic signatures and regional heterogeneity in glioblastomas. J Neurooncol 94: 31-39.
43. Gollapalli K, Ray S, Srivastava R, Renu D, Singh P, et al. (2012) Investigation of serum proteome alterations in human glioblastoma multiforme. Proteomics 12: 2378-2390.
44. Backos DS, Franklin CC, Reigan P, (2012) The role of glutathione in brain tumor drug resistance. Biochem Pharmacol 83(8): 1005-1012.
45. Fujii J, Ito J, Zhang X, Kurahashi T, (2011) Unveiling the roles of the glutathione redox system in vivo by analyzing genetically modified mice. J Clinical Biocehm Nutr 49: 70-78.
46. Ogawa M, Shiozawa M, Hiraoka Y, Takeuchi Y, Also S, (1998) Immunohistochemical study of localization of gamma-glutamyl transpeptidase in the rat brain. Tissue Cell 30: 597-601.
47. Shine HD, Haber B, (1981) Immunocytochemical localization of gamma-glutamyl transpeptidase in the rat CNS. Brain Res 217: 339-349.
48. Papandrikopoulou A, Frey A, Gassen HG, (1989) Cloning and expression of gamma-glutamyl transpeptidase from isolated porcine capillaries. Eur J Biochem 183: 693-698.
49. Sharif SA, Du X, Myles T, Song JJ, Price E, et al. (2009) Thrombin-activatable carboxypeptidase B cleavage of osteopontin regulates neutrophil survival and synoviocyte binding in rheumatoid arthritis. Arthritis Rheum 60: 2902-2912.
50. Pegg CC, He C, Stroink AR, Kattner KA, Wang CX, (2010) Technique for collection of cerebrospinal fluid from the cisterna magna in rat. J Neuroscience Meth 187: 8-12.
51. Ling XB, Cohen H, Jin J, Lau I, Schilling J, (2009) FDR made easy in differential feature discovery and correlation analyses. Bioinformatics 25: 1461-1462.